Special issue of BJP on respiratory pharmacology
β2-adrenoceptor agonists: current and future direction
New perspectives regarding β2-adrenoceptor ligands in the treatment of asthma
Glucocorticosteroids: current and future directions
Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD
Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease
Does airway smooth muscle express an inflammatory phenotype in asthma?
Cytokine/anti-cytokine therapy – novel treatments for asthma?
Genetics of complex respiratory diseases: implications for pathophysiology and pharmacology studies
Is a regenerative approach viable for the treatment of COPD?
Cough: an unmet clinical need
New perspectives for the treatment of pulmonary hypertension
Novel therapeutic approaches for pulmonary fibrosis
New horizons in the treatment of cystic fibrosis
Novel classes of antibiotics or more of the same?
Inhaled innate immune ligands to prevent pneumonia